Voyager Therapeutics (VYGR) Misses Q2 EPS by 4c

Voyager Therapeutics (NASDAQ: VYGR) reported Q2 EPS of ($0.57), $0.04 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $9.5 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trifecta Gold closes $1.66M private placement for Yukon exploration
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold